Search Result |
Top |
Entry | Name | Description | Category | Pathway | Gene |
---|---|---|---|---|---|
H02634 | Deafness, cataract, impaired intellectual development, and polyneuropathy | ... polyneuropathy (DCIDP) is a novel autosomal recessive syndrome with varying degrees of neurosensorial dysfunctions. DCIDP is caused by mutations in PSMC3 gene, encoding the proteasome ATPase subunit Rpt5 ... | Nervous system disease | PSMC3 [HSA:5702] [KO:K03065] | |
H02636 | Sinoatrial node dysfunction and deafness | Sinoatrial node dysfunction and deafness (SANDD) is a genetic disease characterized by a low heart beat and severe-to-profound deafness. A mutation of CACNA1D, encoding the Cav1.3 protein, has been identified ... | Cardiovascular disease; Nervous system disease | CACNA1D [HSA:776] [KO:K04851] | |
H02662 | Sulfide quinone oxidoreductase deficiency | ... ganglia. It has been reported that mutations in SQOR cause this disease. SQOR catabolize hydrogen sulfide. SQOR dysfunction can result in hydrogen sulfide accumulation that inhibits mitochondrial complex IV. | Inherited metabolic disorder | SQOR [HSA:58472] [KO:K22470] | |
H02686 | Developmental delay with dysmorphic facies and dental anomalies | ... dysmorphic facies and dental anomalies (DEFDA) is a neurodevelopmental disorder associated with SATB1 dysfunction. SATB1 encodes a transcription factor with crucial roles in development and maturation of ... | Congenital malformation | (DEFDA/DHDBV) SATB1 [HSA:6304] [KO:K23225] | |
H02695 | Fibrosis, neurodegeneration, and cerebral angiomatosis | ... cerebropulmonary symptoms, malabsorption, growth failure, recurrent infections, hemolytic anemia, liver dysfunction, and lung fibrosis that leads to respiratory failure and death. It has been reported that ... | Congenital malformation | NHLRC2 [HSA:374354] | |
H02698 | Trichohepatoneurodevelopmental syndrome | Trichohepatoneurodevelopmental syndrome (THNS) is a rare autosomal recessive disease characterized by woolly hair, liver dysfunction, dysmorphic features, hypotonia, and global developmental delay. It has been reported that ... | Congenital malformation | CCDC47 [HSA:57003] [KO:K24962] | |
H02705 | Neurodevelopmental disorder with glutamatergic synapse dysfunction | Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) and mediates its actions via activation of both ionotropic and metabotropic receptor families. Recent studies have ... | Nervous system disease |
(NEDLIB) GRIA2 [HSA:2891] [KO:K05198] (NEDSGA) GRIA4 [HSA:2893] [KO:K05200] (NDHMSD/NDHMSR) GRIN1 [HSA:2902] [KO:K05208] (NEDSHBA) GRM7 [HSA:2917] [KO:K04609] (NEDHISB) GNAI1 [HSA:2770] [KO:K04630] (NEDHYDF) GNB2 [HSA:2783] [KO:K04537] |
|
H02727 | Triokinase and FMN cyclase deficiency syndrome | ... deficiency syndrome (TKFCD) is a multisystem disease variably including cataracts, developmental delay, liver dysfunction, cerebellar hypoplasia, and fatal cardiomyopathy with lactic acidosis. TKFC encodes a bifunctional ... | Inherited metabolic disorder | TKFC [HSA:26007] [KO:K00863] | |
H02753 | Vertebral anomalies and variable endocrine and T-cell dysfunction | Vertebral anomalies and variable endocrine and T-cell dysfunction (VETD) is a new multisystem malformation disorder caused by mutations in TBX2. Common clinical manifestations include congenital cardiac ... | Congenital malformation | TBX2 [HSA:6909] [KO:K10176] |
[ KEGG | DISEASE | DRUG | MEDICUS ] |